Editorial
Platelet membrane glycoproteins
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question
Factor XIII (FXIII) and angiogenesis
Inherited defects of coagulation factor V
Inherited defects of coagulation Factor V
The importance of measuring anticardiolipin antibodies
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)
Plasma D-dimer assays in the diagnosis of venous thromboembolism in cancer patients
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis
Adding the vessel wall to Virchow's triad
Thrombin generation in vascular tissue
Hormone replacement therapy and risk of venous thromboembolism – still unresolved questions
New epidemiological risk factors for venous thromboembolism (VTE) after menopause
Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism
Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response
Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
C-reactive protein contributes to the hypercoagulable state in coronary artery disease
Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults
Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement
A rapid enzyme-linked assay for ADAMTS-13
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees
Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion
Identification and characterization of murine alternatively spliced tissue factor
The cleaved and latent forms of antithrombin are normal constituents of blood plasma
Fatal thrombosis of antithrombin-deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice
Molecular bases of type II protein S deficiency
Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI
Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis
Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets
Synthesis of GPIbβ with novel transmembrane and cytoplasmic sequences in a Bernard–Soulier patient resulting in GPIb-defective signaling in CHO cells
The Ser219–>Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype
CHO cells expressing the high affinity αIIbβ3T562N integrin demonstrate enhanced adhesion under shear
Inhibition of 5-hydroxytryptamine2A receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
The regulation of endothelial VWF secretion by nitric oxide
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-β2-glycoprotein-1 ELISAs
A novel compound heterozygous mutation in the F13A gene causing hereditary factor XIII deficiency in a Chinese family
Prophylaxis of venous thromboembolism in general and gynecologic day surgery in the Netherlands
Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis
Protein S binding to phospholipids
Fatty acid ethyl ester, a non-oxidative ethanol metabolite, reverses the inhibitory effect of ibuprofen on platelet aggregation
Deficiency of thrombospondin-1 in mice does not affect adipose tissue development
Accuracy and safety of pretest probability assessment of deep vein thrombosis by physicians in training using the explicit Wells clinical model
No significant improvement in diagnostic specificity of an anti-PF4/polyanion immunoassay with use of high heparin confirmatory procedure
More on
More on
More on
More on
More on
Superficial thrombophlebitis of the legs
Superficial thrombophlebitis of the legs
Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. A rebuttal
Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. Reply to a rebuttal
Announcements